Literature DB >> 20570490

Attention shaping as a means to improve emotion perception deficits in outpatients with schizophrenia and impaired controls.

Dennis R Combs1, Dustin Chapman, Jace Waguspack, Michael R Basso, David L Penn.   

Abstract

Deficits in emotion perception are common in people with schizophrenia and current research has focused on improving these deficits. In our previous research, we demonstrated that directing attention to salient facial features via attention shaping can improve these deficits among inpatients. In this study, we examined the efficacy of an enhanced attention shaping program that contains 192 emotional expressions from which 25 are randomly presented for training. We extended our previous work by using repeated administrations of the shaping intervention and testing its effect in outpatients with schizophrenia and impaired controls. Fifteen participants with schizophrenia and fourteen college student controls with emotion perception deficits were randomly assigned to 1, 3 or 5 sessions of attention shaping. Participants completed 2 outcome measures of emotion perception, the FEIT and BLERT, not presented during the training, and underwent eye tracking at pre and post-tests. All conditions and groups improved, but the largest improvements on the BLERT and FEIT were found for persons assigned to the 5 session condition. Performance on the shaping program was positively correlated with the two outcome measures of emotion perception. There was less support for changes in visual scanning of faces as there was a relative reduction in total scanning time from pre-test to post-test. Results are interpreted in terms of the efficacy of attention shaping as a means to improve emotion perception deficits.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20570490     DOI: 10.1016/j.schres.2010.05.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  A meta-analysis of emotion perception and functional outcomes in schizophrenia.

Authors:  Farzin Irani; Sarah Seligman; Vidyulata Kamath; Christian Kohler; Ruben C Gur
Journal:  Schizophr Res       Date:  2012-02-15       Impact factor: 4.939

2.  Oxytocin increases eye gaze in schizophrenia.

Authors:  Ellen R Bradley; Alison Seitz; Andrea N Niles; Katherine P Rankin; Daniel H Mathalon; Aoife O'Donovan; Joshua D Woolley
Journal:  Schizophr Res       Date:  2019-08-12       Impact factor: 4.939

3.  Eye Tracking of Attention to Emotion in Bipolar I Disorder: Links to Emotion Regulation and Anxiety Comorbidity.

Authors:  Andrew D Peckham; Sheri L Johnson; Jordan A Tharp
Journal:  Int J Cogn Ther       Date:  2016-12

4.  Eye tracking young children with autism.

Authors:  Noah J Sasson; Jed T Elison
Journal:  J Vis Exp       Date:  2012-03-27       Impact factor: 1.355

5.  Do Apparent Overlaps between Schizophrenia and Autistic Spectrum Disorders Reflect Superficial Similarities or Etiological Commonalities?

Authors:  William S Stone; Lisa Iguchi
Journal:  N Am J Med Sci (Boston)       Date:  2011-07-25

6.  Can Social Functioning in Schizophrenia Be Improved through Targeted Social Cognitive Intervention?

Authors:  David L Roberts; Dawn I Velligan
Journal:  Rehabil Res Pract       Date:  2012-06-13

7.  Facial expression training optimises viewing strategy in children and adults.

Authors:  Petra M J Pollux; Sophie Hall; Kun Guo
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

8.  A quasi-randomized feasibility pilot study of specific treatments to improve emotion recognition and mental-state reasoning impairments in schizophrenia.

Authors:  Pamela Jane Marsh; Vince Polito; Subba Singh; Max Coltheart; Robyn Langdon; Anthony W Harris
Journal:  BMC Psychiatry       Date:  2016-10-24       Impact factor: 3.630

9.  Social and Neurocognitive Deficits in Remitted Patients with Schizophrenia, Schizoaffective and Bipolar Disorder.

Authors:  Liana Dehelean; Ana Maria Romosan; Bianca Oana Bucatos; Ion Papava; Rita Balint; Ana Maria Cristina Bortun; Mirela Marioara Toma; Simona Bungau; Radu Stefan Romosan
Journal:  Healthcare (Basel)       Date:  2021-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.